109 related articles for article (PubMed ID: 26711331)
41. Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells.
Matoba K; Kawanami D; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K
Biochem Biophys Res Commun; 2010 Nov; 402(4):725-30. PubMed ID: 20977889
[TBL] [Abstract][Full Text] [Related]
42. Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation.
Zhao Z; Rivkees SA
Dev Dyn; 2003 Jan; 226(1):24-32. PubMed ID: 12508221
[TBL] [Abstract][Full Text] [Related]
43. Small guanine nucleotide-binding protein Rho and myocardial function.
Ren J; Fang CX
Acta Pharmacol Sin; 2005 Mar; 26(3):279-85. PubMed ID: 15715922
[TBL] [Abstract][Full Text] [Related]
44. The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice.
Williams J; Bogwu J; Oyekan A
J Hypertens; 2006 Jul; 24(7):1429-36. PubMed ID: 16794494
[TBL] [Abstract][Full Text] [Related]
45. Rho‑associated kinase inhibitor, Y‑27632, inhibits the invasion and proliferation of T24 and 5367 bladder cancer cells.
Jiang L; Wen J; Luo W
Mol Med Rep; 2015 Nov; 12(5):7526-30. PubMed ID: 26459851
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase.
Krijnen PA; Sipkens JA; Molling JW; Rauwerda JA; Stehouwer CD; Muller A; Paulus WJ; van Nieuw Amerongen GP; Hack CE; Verhoeven AJ; van Hinsbergh VW; Niessen HW
J Mol Cell Cardiol; 2010 Nov; 49(5):781-90. PubMed ID: 20691698
[TBL] [Abstract][Full Text] [Related]
47. SMN deficiency attenuates migration of U87MG astroglioma cells through the activation of RhoA.
Caraballo-Miralles V; Cardona-Rossinyol A; Garcera A; Villalonga P; Soler RM; Olmos G; Lladó J
Mol Cell Neurosci; 2012 Mar; 49(3):282-9. PubMed ID: 22197680
[TBL] [Abstract][Full Text] [Related]
48. RhoA GTPase regulates radiation-induced alterations in endothelial cell adhesion and migration.
Rousseau M; Gaugler MH; Rodallec A; Bonnaud S; Paris F; Corre I
Biochem Biophys Res Commun; 2011 Nov; 414(4):750-5. PubMed ID: 22001926
[TBL] [Abstract][Full Text] [Related]
49. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho.
Pfeiffer ZA; Aga M; Prabhu U; Watters JJ; Hall DJ; Bertics PJ
J Leukoc Biol; 2004 Jun; 75(6):1173-82. PubMed ID: 15075366
[TBL] [Abstract][Full Text] [Related]
50. Clostridium perfringens TpeL Induces Formation of Stress Fibers via Activation of RhoA-ROCK Signaling Pathway.
Nagahama M; Ohkubo A; Kinouchi Y; Kobayashi K; Miyamoto K; Takehara M; Sakurai J
Biol Pharm Bull; 2015; 38(5):732-9. PubMed ID: 25947919
[TBL] [Abstract][Full Text] [Related]
51. Y-39983, a selective Rho-kinase inhibitor, attenuates experimental autoimmune encephalomyelitis via inhibition of demyelination.
Gao C; Huang L; Long Y; Zheng J; Yang J; Pu S; Xie L
Neuroimmunomodulation; 2013; 20(6):334-40. PubMed ID: 24008512
[TBL] [Abstract][Full Text] [Related]
52. Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.
Akhmetshina A; Dees C; Pileckyte M; Szucs G; Spriewald BM; Zwerina J; Distler O; Schett G; Distler JH
Arthritis Rheum; 2008 Aug; 58(8):2553-64. PubMed ID: 18668558
[TBL] [Abstract][Full Text] [Related]
53. Rho/ROCK pathway as a target of tumor therapy.
Rattan R; Giri S; Singh AK; Singh I
J Neurosci Res; 2006 Feb; 83(2):243-55. PubMed ID: 16385577
[TBL] [Abstract][Full Text] [Related]
54. Ouabain-induced apoptosis and Rho kinase: a novel caspase-2 cleavage site and fragment of Rock-2.
Ark M; Ozdemir A; Polat B
Apoptosis; 2010 Dec; 15(12):1494-506. PubMed ID: 20661774
[TBL] [Abstract][Full Text] [Related]
55. ROCK-2 is associated with focal adhesion maturation during myoblast migration.
Goetsch KP; Snyman C; Myburgh KH; Niesler CU
J Cell Biochem; 2014 Jul; 115(7):1299-307. PubMed ID: 24700588
[TBL] [Abstract][Full Text] [Related]
56. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
[TBL] [Abstract][Full Text] [Related]
57. Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway.
Ji H; Meng Y; Zhang X; Luo W; Wu P; Xiao B; Zhang Z; Li X
Regul Pept; 2011 Aug; 169(1-3):13-20. PubMed ID: 21545816
[TBL] [Abstract][Full Text] [Related]
58. Macrophage phenotype bioengineered by magnetic, genetic, or pharmacologic interference.
Wosik J; Suarez-Villagran M; Miller JH; Ghobrial RM; Kloc M
Immunol Res; 2019 Feb; 67(1):1-11. PubMed ID: 30649660
[TBL] [Abstract][Full Text] [Related]
59. The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy.
Gui P; Ben-Neji M; Belozertseva E; Dalenc F; Franchet C; Gilhodes J; Labrousse A; Bellard E; Golzio M; Poincloux R; Maridonneau-Parini I; Le Cabec V
Cancer Immunol Res; 2018 Nov; 6(11):1337-1351. PubMed ID: 30181209
[TBL] [Abstract][Full Text] [Related]
60. Aberrant activation of Rho/ROCK signaling in impaired polarity switching of colorectal micropapillary carcinoma.
Onuma K; Sato Y; Okuyama H; Uematsu H; Homma K; Ohue M; Kondo J; Inoue M
J Pathol; 2021 Sep; 255(1):84-94. PubMed ID: 34156098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
